Cytokinetics (CYTK) Misses Q3 EPS by 59c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $80.01 +1.06%
Revenue Growth %: -75.4%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -75.4%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.35), $0.59 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Green Dot and CommerceOne shareholders approve acquisition deal
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
